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Background
Nasopharyngeal carcinoma (NPC) is a condition that pre-
dominantly affects the population of South China (2–3
cases/100 000). At the present time, the conventional
treatment of NPC is with chemoradiotherapy. This has
revolutionised the prognosis and 5-year survival rates are
of the order of 50–70%, size dependent. Treatment of
recurrence is however difficult. Surgery is an option but
suited to small localised recurrence; re-irradiation can
cause demyelination and chemotherapy has very small
complete response rates. Photodynamic therapy (PDT) is
approved for the treatment of advanced or recurrent head
and neck cancers.
Materials and methods
We describe a series of 5 patients treated with PDT for
recurrent NPC all of whom had unsuccessful conven-
tional therapy. The patients were treated with Foscan 0.15
mg/kg, 4 days prior to illumination with red light of 652
nm from a diode laser. The technique of light application
is described as well as the clinical response.
Results
Of the 5 patients treated, local control was achieved in 4/
5 patients. A standard regimen of controlled exposure to
light was followed over a 4–6 weeks period and no pho-
totoxic events were recorded. Apart from transient pain
and swelling, there were no complications or side effects
from the treatment itself. It should be noted that some
patients underwent more than one PDT treatment.
Conclusion
In this group who had failed previous conventional ther-
apy, PDT is clearly a useful therapeutic option. It has low
morbidity, is repeatable and is not prejudiced by prior
therapy.
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